Arthur M. Bruskin
Keine laufenden Positionen mehr
Profil
Arthur M.
Bruskin served as the Chief Scientific Officer at Interpath Pharmaceuticals, Inc. from 2005 to 2006.
He then worked as the Chief Operating Officer at Eutropics Pharmaceuticals, Inc. from 2006 to 2008.
From 2008 to 2012, he was an Independent Director at Arbutus Biopharma Corp.
and also served as the Executive Vice President-Global Research at OSI Pharmaceuticals, Inc. Dr. Bruskin holds a doctorate degree from Indiana University and undergraduate and graduate degrees from the University of Connecticut.
Ehemalige bekannte Positionen von Arthur M. Bruskin
| Unternehmen | Position | Ende |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Direktor/Vorstandsmitglied | 01.06.2012 |
Eutropics Pharmaceuticals, Inc.
 Eutropics Pharmaceuticals, Inc. Internet Software/ServicesTechnology Services Eutropics Pharmaceuticals, Inc. operates as a biomarker technology platform for accelerating drug discovery and development. The private company is based in Cambridge, MA. The company was founded in 2005 by Gary E. Frashier, Michael Cardone. Michael Cardone has been the CEO since 2005. | Geschäftsführer | 01.01.2008 |
Interpath Pharmaceuticals, Inc.
 Interpath Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Interpath Pharmaceuticals, Inc. develops cancer therapeutics based on liposomal delivery technology for antisense. The company was founded in 2001 by Gabriel Lopez-Berestein and Peter Nielsen and is headquartered in Houston, TX | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2002 |
Ausbildung von Arthur M. Bruskin
| Indiana University | Doctorate Degree |
| University of Connecticut | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Interpath Pharmaceuticals, Inc.
Interpath Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Interpath Pharmaceuticals, Inc. develops cancer therapeutics based on liposomal delivery technology for antisense. The company was founded in 2001 by Gabriel Lopez-Berestein and Peter Nielsen and is headquartered in Houston, TX | Health Technology |
Eutropics Pharmaceuticals, Inc.
Eutropics Pharmaceuticals, Inc. Internet Software/ServicesTechnology Services Eutropics Pharmaceuticals, Inc. operates as a biomarker technology platform for accelerating drug discovery and development. The private company is based in Cambridge, MA. The company was founded in 2005 by Gary E. Frashier, Michael Cardone. Michael Cardone has been the CEO since 2005. | Technology Services |
